ablack

Berta Raventós

Epidemiologist 

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Social: linkedin logo

 

 

 

 

 

 

 

 

Background

Berta Raventós is a postdoctoral research, and works as an epidemiologist and principal investigator within the Data Analysis and Real World Interrogation Network (DARWIN EU®).

Berta is a Biosystems Engineer (2016) by training and holds an MSc in Microbiology (2017) and an MSc in Biostatistics and Bioinformatics (2021). She received formal training in epidemiology and observational research and completed a PhD in Methodological Research and Public Health at the Universitat Autònoma de Barcelona (2024).

Her research interests focus on the secondary use of healthcare data for epidemiological research. She has experience conducting multi-database epidemiological studies using real-world data, as well as contributing to the development of tools to analyze data mapped to the OMOP Common Data Model. 

Relevant publications:

Mercade-Besora N*, Raventós B*, Nhung TH Trinh, et al. Effectiveness of COVID-19 mRNA primary and booster vaccination against infection and hospitalisation during pregnancy: a target trial emulation and meta-analysis of data from 4 European countries. medRxiv [Preprint]. May 16, 2025. doi:10.1101/2025.05.16.25327593.

Raventós B, Prieto-Alhambra D. Real-world evidence for regulatory purposes: The example of DARWIN EU®. Farm Hosp. 2025;49(2):62-64. doi:10.1016/j.farma.2025.02.011.

Raventós B*, Català M*, Du M, et al. IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model. Pharmacoepidemiol Drug Saf. 2024;33(1):e5717. doi:10.1002/pds.5717.

Raventós B*, Fernández-Bertolín S*, Aragón M, et al. Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research. Clin Epidemiol. 2023;15:969-986. Published 2023 Sep 13. doi:10.2147/CLEP.S419481.

Guo Y*, Raventós B*, Català M, et al. Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones. Pharmacoepidemiol Drug Saf. 2024;33(10):e70022. doi:10.1002/pds.70022.

Li X*, Raventós B*, Roel E, et al. Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis. BMJ. 2022;376:e068373. Published 2022 Mar 16. doi:10.1136/bmj-2021-068373.

*Joint first-authors.

DARWIN EU® studies (Principal Investigator role):

DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics (EUPAS1000000329 and EUPAS1000000584).

DARWIN EU ® – Impact of risk minimisation measures related to the risk of meningioma in women using nomegestrol and chlormadinone (EUPAS1000000455).

DARWIN EU ® – Prevalence of selected cancers (EUPAS1000000715)